Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

464 public trials 49 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Not yet recruiting

Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)

NCT06663189

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • CHU de Bordeaux-Hôpital Pellegrin Bordeaux, France
  • CHU de Caen-Hôpital Côte de Nacre Caen, France
  • CHU de Clermont-Ferrand-Hôpital Gabriel Montpied Clermont-Ferrand, France
  • Assistance Publique des Hôpitaux de Paris (APHP)-Hôpital Henri Mondor Créteil, France
View all 22 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

NCT03958877

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • UC San Diego Health La Jolla, California, United States
  • UNC Hospitals Chapel Hill, North Carolina, United States
  • Meridian Clinical Research Norfolk, Virginia, United States
  • Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
View all 65 locations
View Trial Details

Related conditions